Company Filing History:
Years Active: 2002
Title: Francis P. Cammack: Innovator in Transgenic Maize Technology
Introduction
Francis P. Cammack is a notable inventor based in Rochelle, IL (US). He has made significant contributions to the field of agricultural biotechnology, particularly in the development of transgenic maize. His innovative methods have the potential to enhance crop production and improve food security.
Latest Patents
Cammack holds a patent for a method of producing transgenic maize using direct transformation of commercially important genotypes. This patent, titled "Method of producing transgenic maize using direct transformation of commercially important genotypes," discloses methods for transforming maize with nucleic acid sequences of interest. The technique involves subjecting immature zygotic embryos or Type I callus to high-velocity microprojectile bombardment. This method is capable of producing transformed maize lines of commercial importance and their hybrid combinations. He has 1 patent to his name.
Career Highlights
Cammack is associated with Syngenta Investment Corporation, a leading company in agricultural innovation. His work focuses on enhancing the genetic traits of maize, which is crucial for meeting the demands of a growing global population. His research has implications for both agricultural practices and food production.
Collaborations
Some of his notable coworkers include Michael G. Koziel and Nalini M. Desai. Their collaborative efforts have contributed to advancements in the field of plant biotechnology.
Conclusion
Francis P. Cammack's work in transgenic maize technology exemplifies the importance of innovation in agriculture. His contributions are paving the way for more efficient and sustainable farming practices.